Abstract
Prolonged Partial Response to Osimertinib after Disease Progression to Rociletinib in Metastasic EGFR T790M-Positive Non–Small Cell Lung Cancer
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have